News

FDA delays approval decision for Bayer menopause therapy
The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...
Boise State Public Radio5h
Doctors urge FDA to remove black box warning on hormone therapy for menopause
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
Bayer's elinzanetant review period gets extended by FDA
Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.
Her Agenda on MSN7h
F.D.A. Discusses Removal Of Most Severe Warning On Menopause Treatments
At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on ...
Iowa Public Radio9h
Warning labels on menopause treatments 'scare women,' doctors tell the FDA
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
The Highland County Press10h
FDA 'rewriting' food pyramid guidelines
U.S. Food and Drug Administration Commissioner Marty Makary said he is focused on overhauling long-held standards and ...